Attached files
| file | filename |
|---|---|
| 10-K - CardioGenics Holdings Inc. | v173825_10k.htm |
| EX-31.1 - CardioGenics Holdings Inc. | v173825_ex31-1.htm |
| EX-31.2 - CardioGenics Holdings Inc. | v173825_ex31-2.htm |
| EX-21.1 - CardioGenics Holdings Inc. | v173825_ex21-1.htm |
| EX-23.1 - CardioGenics Holdings Inc. | v173825_ex23-1.htm |
| EX-10.29 - CardioGenics Holdings Inc. | v173825_ex10-29.htm |
| EX-10.28 - CardioGenics Holdings Inc. | v173825_ex10-28.htm |
| EX-10.30 - CardioGenics Holdings Inc. | v173825_ex10-30.htm |
| EX-10.31 - CardioGenics Holdings Inc. | v173825_ex10-31.htm |
| EX-32.1 - CardioGenics Holdings Inc. | v173825_ex32-1.htm |
EXHIBIT 23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation
by reference in the Registration Statements on Form S-8 (No. 333-137162) of
CardioGenics Holdings Inc. of our report dated July 29, 2009 relating to
the consolidated balance sheet of CardioGenics Holdings Inc. [formerly
CardioGenics Inc., (a development stage company)], as of October 31, 2008 and
the related consolidated statements of operations, stockholders’ equity
(deficit) and cash flows for the year then ended, which appears in this Annual
Report on Form 10-K. Our report contains an explanatory paragraph
regarding the Company’s ability to continue as a going concern.
(Signed)
“BDO Canada
LLP”
Chartered
Accountants, Licensed Public Accountants
Toronto,
Ontario
February
12, 2010